Publications by authors named "Derieppe M"

Background And Aim: Standard rectal cancer treatment includes neoadjuvant radiotherapy sensitized by 5-fluorouracil (5-FU) chemotherapy. However, 5-FU increased chemoradiotherapy response rate comes with significant toxicity, especially in older, frail patients. The development of alternatives to chemotherapy enabling radiosensitization with limited systemic toxicity is therefore needed to improve patient management.

View Article and Find Full Text PDF

Undifferentiated pleomorphic sarcoma (UPS) is the most frequent and the most aggressive sarcoma subtype for which therapeutic options are limited. The identification of new therapeutic strategies is therefore an important medical need. Epigenetic modifiers has been extensively investigated in recent years leading to the development of novel therapeutic agents.

View Article and Find Full Text PDF

Unlabelled: Phosphatase of regenerating liver 2 (also known as PTP4A2) has been linked to cancer progression. Still, its exact role in glioblastoma (GBM), the most aggressive type of primary brain tumor, remains elusive. In this study, we report that pharmacologic treatment using JMS-053, a pan-phosphatase of regenerating liver inhibitor, inhibits GBM cell viability and spheroid growth.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is linked to inflammation and can arise from liver diseases, leading to an increase in immunosuppressive myeloid cells, which complicates immunotherapy effectiveness.
  • A detailed study of innate immune cells in HCC patients revealed an influx of inflammatory and myeloid cells, particularly a distinct type of THBS1 regulatory myeloid cells, which are associated with poor patient outcomes.
  • THBS1 M cells, marked by specific gene expressions and characterized by their role in promoting tumor growth and immunosuppression, suggest that targeting these myeloid subsets could improve HCC immunotherapy strategies.
View Article and Find Full Text PDF

Cancer cells are exposed to major compressive and shearing forces during invasion and metastasis, leading to extensive plasma membrane damage. To survive this mechanical stress, they need to repair membrane injury efficiently. Targeting the membrane repair machinery is thus potentially a new way to prevent invasion and metastasis.

View Article and Find Full Text PDF

Purpose: Patients with advanced soft-tissue sarcomas (STS) exhibit a poor prognosis and have few therapeutic options. DNA-dependent protein kinase (DNA-PK) catalytic subunit is a multifunctional serine-threonine protein kinase that plays a crucial role in DNA double-strand damage repair via nonhomologous end joining.

Experimental Design: To investigate the therapeutic potential of DNA-PK targeting in STS, we first evaluated the prognostic value of DNA-PK expression in two large cohorts of patients with STS.

View Article and Find Full Text PDF
Article Synopsis
  • Soft-tissue sarcoma (STS) is a rare and aggressive tumor type with a high fatality rate due to metastasis and poor treatment options.
  • Researchers found that inhibiting the ATM signaling network can counteract resistance to the ATR inhibitor AZD6738, using CRISPR/Cas9 techniques to validate their findings.
  • The combination of AZD6738 and ATM inhibitor AZD0156 significantly enhances the effectiveness of treatment, leading to increased DNA damage and tumor growth reduction in various STS types.
View Article and Find Full Text PDF

Background And Purpose: Diffuse midline glioma H3K27-altered (DMG) is an aggressive, inoperable, predominantly paediatric brain tumour. Treatment strategies are limited, resulting in a median survival of only 11 months. Currently, radiotherapy (RT), often combined with temozolomide, is considered the standard of care but remains palliative, highlighting the urgency for new therapies.

View Article and Find Full Text PDF

Diffuse midline glioma (DMG) is an aggressive brain tumour with high mortality and limited clinical therapeutic options. Although in vitro research has shown the effectiveness of medication, successful translation to the clinic remains elusive. A literature search highlighted the high variability and lack of standardisation in protocols applied for establishing the commonly used HSJD-DIPG-007 patient-derived xenograft (PDX) model, based on animal host, injection location, number of cells inoculated, volume, and suspension matrices.

View Article and Find Full Text PDF

Lungs are the most frequent site of metastases growth. The amount and size of pulmonary metastases acquired from MRI imaging data are the important criteria to assess the efficacy of new drugs in preclinical models. While efficient solutions both for MR imaging and the downstream automatic segmentation have been proposed for human patients, both MRI lung imaging and segmentation in preclinical animal models remains challenging due to the physiological motion (respiratory and cardiac movements), to the low amount of protons in this organ and to the particular challenge of precise segmentation of metastases.

View Article and Find Full Text PDF

Lactate is a central metabolite in brain physiology but also contributes to tumor development. Glioblastoma (GB) is the most common and malignant primary brain tumor in adults, recognized by angiogenic and invasive growth, in addition to its altered metabolism. We show herein that lactate fuels GB anaplerosis by replenishing the tricarboxylic acid (TCA) cycle in absence of glucose.

View Article and Find Full Text PDF
Article Synopsis
  • - Radiosensitizing glioblastoma is crucial for improving survival rates, and this study investigates the effects of 5-aminolevulinic acid (5-ALA), which accumulates a metabolite called protoporphyrin IX (PpIX) with potential radiosensitization.
  • - Using patient-derived tumor cell lines in a brain tumor model, the study tested different radiation therapy regimens, finding that while 5-ALA treatment was associated with significant PpIX accumulation, it did not enhance survival or inhibit tumor growth compared to radiation alone.
  • - The findings indicate that in relevant glioblastoma models, 5-ALA does not boost the effectiveness of standard radiotherapy, showing no significant difference
View Article and Find Full Text PDF

Glioblastoma (GB) are the most frequent brain cancers. Aggressive growth and limited treatment options induce a median survival of 12-15 months. In addition to highly proliferative and invasive properties, GB cells show cancer-associated metabolic characteristics such as increased aerobic glycolysis.

View Article and Find Full Text PDF

Radiotherapy (RT) is a cornerstone treatment strategy for brain tumours. Besides cytotoxicity, RT can cause disruption of the blood-brain barrier (BBB), resulting in an increased permeability into the surrounding brain parenchyma. Although this effect is generally acknowledged, it remains unclear how and to what extent different radiation schemes affect BBB integrity.

View Article and Find Full Text PDF

Background: Despite the improvement of medulloblastoma (MB) treatments, survivors face severe long-term adverse effects and associated morbidity following multimodal treatments. Moreover, relapses are fatal within a few months. Therefore, chemotherapies inducing fewer adverse effects and/or improving survival at relapse are key for MB patients.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer immunotherapy has changed adult cancer treatment and shows potential for treating pediatric cancers, but there is a need for better test systems to evaluate these therapies.
  • * The study presents a new ex vivo coculture system that uses pediatric tumor organoids and immune cells, allowing for real-time assessment of immunotherapy effectiveness.
  • * The researchers demonstrated the system's capability by testing the immunotherapy dinutuximab on neuroblastoma organoids, proving it as a viable method for personalized treatment strategies in pediatric oncology.
View Article and Find Full Text PDF
Article Synopsis
  • Obesity is increasing globally, and recent research highlights that fathers with poor diets can negatively impact their offspring's metabolic health.
  • A study using mice demonstrated that multiple generations of fathers fed a Western diet led to increased fat mass and metabolic issues in their descendants, even when those offspring were fed a healthier diet.
  • Interestingly, while these offspring developed an 'overweight' phenotype without certain metabolic diseases, sperm RNA injection studies indicate that while sperm RNA can trigger epigenetic changes related to metabolism, it does not sustain those changes over the long term.
View Article and Find Full Text PDF

Impaired cerebrovascular function is an early biomarker for cerebral amyloid angiopathy (CAA), a neurovascular disease characterized by amyloid-β accumulation in the cerebral vasculature, leading to stroke and dementia. The transgenic Swedish Dutch Iowa (Tg-SwDI) mouse model develops cerebral microvascular amyloid-β deposits, but whether this leads to similar functional impairments is incompletely understood. We assessed cerebrovascular function longitudinally in Tg-SwDI mice with arterial spin labeling (ASL)-magnetic resonance imaging (MRI) and laser Doppler flowmetry (LDF) over the course of amyloid-β deposition.

View Article and Find Full Text PDF

The gene is amplified in dedifferentiated liposarcoma (DDLPS). Treatment with MDM2 antagonists is a promising strategy to treat DDLPS; however, drug resistance is a major limitation when these drugs are used as a single agent. This study examined the impact of MDM2 antagonists on the mitogen-activated protein kinase (MAPK) pathway in DDLPS and investigated the potential synergistic activity of a MAPK kinase (MEK) inhibitor in combination with MDM2 antagonists.

View Article and Find Full Text PDF

The blood-brain barrier (BBB) has been a major hurdle for the treatment of various brain diseases. Endothelial cells, connected by tight junctions, form a physiological barrier preventing large molecules (>500 Da) from entering the brain tissue. Microbubble-mediated focused ultrasound (FUS) can be used to induce a transient local BBB opening, allowing larger drugs to enter the brain parenchyma.

View Article and Find Full Text PDF
Article Synopsis
  • CADASIL is a disease linked to NOTCH3 that affects small blood vessels in the brain, characterized by GOM deposits in arteries; however, how these deposits form and affect disease progression is not well understood.
  • Researchers studied GOM deposits in genetically modified mice and human patients, discovering that these deposits are dynamic and grow larger and more complex as the mice age, which led to the creation of a new classification system.
  • Despite similarities in GOM stages between mice and humans, the mutant mice didn't develop the most severe GOM seen in patients, highlighting a lack of severe associated brain damage and cognitive deficits, suggesting the need for further research on GOM's role in CADASIL.
View Article and Find Full Text PDF

Arterial spin labeling (ASL)-MRI can noninvasively map cerebral blood flow (CBF) and cerebrovascular reactivity (CVR), potential biomarkers of cognitive impairment and dementia. Mouse models of disease are frequently used in translational MRI studies, which are commonly performed under anesthesia. Understanding the influence of the specific anesthesia protocol used on the measured parameters is important for accurate interpretation of hemodynamic studies with mice.

View Article and Find Full Text PDF

In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), from thermosensitive liposomes (TSLs) can be an option to overcome poor extravasation of drug nanocarriers.

View Article and Find Full Text PDF

Background And Aims: Success in delivering value-based healthcare involves measuring outcomes that matter most to patients. Our aim was to develop a minimum Standard Set of patient-centred outcome measures for inflammatory bowel disease [IBD], for use in different healthcare settings.

Methods: An international working group [n = 25] representing patients, patient associations, gastroenterologists, surgeons, specialist nurses, IBD registries and patient-reported outcome measure [PROM] methodologists participated in a series of teleconferences incorporating a modified Delphi process.

View Article and Find Full Text PDF